Company logo Company name logo
Attention Investors
Kindly note the Change in PAY IN for BSE A/C No. : 1201250000000691 (CDSL), if you have an NSDL A/C, kindly use INTER DEPOSITORY SLIP. For assistance, please call OR contact: Mr. Dadu, 98339 89807 / 022-6145 1000.     |     Exchanges / Depository: Prevent Unauthorized Transactions in your Trading / Demat account --> Update your Mobile Numbers / email IDs with your Stock Brokers / Depository Participant. Receive alerts on your Registered Mobile / email IDs for trading account transactions and all debit and other important transactions in your demat account directly from Exchange / Depository on the same day ......................Issued in the interest of Investors.     |     KYC : "KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."     |     ASBA-IPO : "No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
tiker sep
plus stop minus
 
 
Titan Biotech LtdIndustry : Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code:524717NSE Symbol: Not ListedP/E(TTM):56.07
ISIN Demat:INE150C01029Div & Yield %:0.12EPS(TTM):7.44
Book Value(Rs):41.3474594Market Cap (rupee Cr.):1723.6Face Value(Rs):2
    
(rupee In Cr)
 Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021
INCOME :      
Sales Turnover 206.19156.45164.07144.00123.55122.46
Excise Duty0.000.000.000.000.000.00
Net Sales206.19156.45164.07144.00123.55122.46
Other Income 5.413.911.751.940.940.75
Stock Adjustments 2.972.855.290.930.172.23
Total Income214.57163.21171.11146.87124.66125.44
EXPENDITURE :      
Raw Materials 103.9979.3485.3374.6161.6457.58
Power & Fuel Cost12.769.8310.248.986.674.10
Employee Cost 32.3626.3823.7118.2114.2411.08
Other Manufacturing Expenses 5.153.924.103.442.963.77
Selling and Administration Expenses 15.0413.4410.759.216.425.66
Miscellaneous Expenses 1.260.960.950.960.521.05
Less: Pre-operative Expenses Capitalised0.000.000.000.000.000.00
Total Expenditure170.56133.88135.07115.4292.4683.23
Operating Profit44.0129.3436.0331.4732.2142.20
Interest 0.910.801.170.750.871.33
Gross Profit43.1028.5434.8630.7231.3440.87
Depreciation4.934.173.332.602.372.10
Profit Before Tax38.1724.3731.5328.1228.9738.77
Tax9.895.977.767.187.359.86
Fringe Benefit tax0.000.000.000.000.000.00
Deferred Tax0.840.120.11-0.09-0.070.13
Reported Net Profit27.4518.2723.6621.0221.6828.77
Extraordinary Items 0.000.000.000.000.00-0.24
Adjusted Net Profit27.4518.2723.6621.0221.6829.01
Adjst. below Net Profit 0.000.000.000.000.000.00
P & L Balance brought forward127.80111.1889.0069.2248.7720.83
Statutory Appropriations 0.000.000.000.000.000.00
Appropriations 1.651.651.491.241.240.83
P & L Balance carried down153.59127.80111.1889.0069.2248.77
Dividend0.000.000.000.000.000.00
Preference Dividend0.000.000.000.000.000.00
Equity Dividend %25.0020.0020.0018.0015.0015.00
Earnings Per Share-Unit Curr6.6422.1128.6425.4426.2434.82
Earnings Per Share(Adj)-Unit Curr6.6422.1128.6425.4426.2434.82
Book Value-Unit Curr41.35175.63155.43128.38104.3679.65